Navigation Links
New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
Date:2/18/2010

CHAPEL HILL, N.C., Feb. 18 /PRNewswire/ -- Companies invest hundreds of millions – and occasionally billions – of dollars overall in developing new drugs and face countless hurdles in bringing these new products to market.  To make good on these vast investments, successful companies must maximize product uptake across all customer groups: not only among patients and physicians, but also among government and private payers to win formulary access and improve product placement.  

In fact, these payer groups, who represent millions of individual consumers, compose biopharma's largest revenue base and earning a favorable formulary tier position with a single large carrier can open the door to hundreds of millions in potential revenue.

Companies face two main problems in gaining traction with large payer groups. First, since the market for most therapeutic areas and medical conditions is already crowded with similar treatments, companies must to be able to articulate a clear medical or economic advantage for their products.  Second, companies often struggle to gain access to key decision makers within the Managed Markets organization.

By anticipating payer attitudes and behavior early on in the product lifecycle, a high-functioning Managed Markets market research group can prove invaluable in setting clinical and commercial strategy.  In addition, savvy Managed Markets market research groups also provide vital insight and value by delivering reliable and actionable knowledge of the ever evolving Managed Markets landscape.  

A new benchmarking study from Best Practices, LLC, Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight, explores the proven strategies that best-in-class companies have mastered.  With a benchmark class that features Abbott, GSK, Johnson & Johnson and Novo Nordisk among others, this research examines dozens of Managed Markets market research activities all of which help companies meet new regulatory and legislative challenges and build fruitful relationships with key decision makers at large payer organizations.

To download a complimentary study excerpt, or to view a sample of key topics and study findings, go to: http://www3.best-in-class.com/rr989.htm .

To learn more about Best Practices' other timely research visit: http://www3.best-in-class.com or contact Benjamin Gregory at 919-767-9160 or bgregory@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC

RELATED LINKS
http://www3.best-in-class.com/

'/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johns Hopkins Medicine Acquires Naviscan PEM Technology for Novel Radiotracer Research
2. IPA Helps Researchers Utilize and Share Current Disease Knowledge Through New Dynamic Reporting Capability
3. Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine
4. US HIFU Partners with Riverside Research Institute to Add Cancer Targeting Technology to HIFU Treatment
5. Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research
6. Northern Light Surpasses $2 Billion Worth of Research Content Integrated Into SinglePoint Strategic Research Portals
7. New Research Gives Insight to the Frequency of Doctor Shopping Occurring Within Prescription Monitoring Programs
8. Medical Research Council Technologys Centre for Therapeutics Discovery Opens its First Call For Targets in an Effort to Develop Drugs in Areas of Serious Unmet Need
9. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
10. ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report
11. Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... May 25, 2016  Zymo Research Corp. announced ... new reference materials that help researchers obtain the ... to analyses. The rapid growth of the study ... to have standard methods to improve the reproducibility ... inherently exist at every step of the measurement ...
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today ... test for wounds and infections. This test ensures ... and select viruses. The test requires only a ... David G. Bostwick , MD, ... to facilitate wound healing: "We are excited to ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting ... and company to wait until March 2017 for an interest rate increase, according to ... College of Business. , “The Federal Open Market Committee (FOMC) dot charts are of ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to expand ... Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final WNBA ... levels of the game, Connor Sports has committed to a significantly increased focus on ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
Breaking Medicine News(10 mins):